Anne-Claire Fougerousse

Dr. Anne-Claire Fougerousse


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
ZRZ. Reguiaï
Z. Reguiaï
AFAnne-Claire Fougerousse
Anne-Claire Fougerousse
FMF. Maccari
F. Maccari
PBP.A. Bécherel
P.A. Bécherel

20 April 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AFAnne-Claire Fougerousse
Anne-Claire Fougerousse
PGPierre‐Dominique Ghislain
Pierre‐Dominique Ghislain
ZRZiad Reguiai
Ziad Reguiai
FMFrançois Maccari
François Maccari
JPJosiane Parier
Josiane Parier
FRFor the GEM ResoPso
For the GEM ResoPso

21 June 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
AFAnne-Claire Fougerousse
Anne-Claire Fougerousse
MPM. Perrussel
M. Perrussel
PBP.‐A. Bécherel
P.‐A. Bécherel
EBE. Begon
E. Begon
VPV. Pallure
V. Pallure
TRThe Gem Resopso
The Gem Resopso
Click on the article title to read more.

15 July 2024 in Annales de Dermatologie et de Vénéréologie
Verified
Journal Article
Open access
FPF. Poizeau
F. Poizeau
SLS. Leducq
S. Leducq
LFL. Fardet
L. Fardet
Marie BEYLOT-BARRYMarie BEYLOT-BARRY
Marie BEYLOT-BARRY
GCGuillaume Chaby
Guillaume Chaby
BGB. Guillot
B. Guillot
New highly effective drugs for moderate-to-severe cutaneous psoriasis are regularly marketed, and the hierarchy of treatments thus requires frequent review. A Delphi method was used to enable a structured expert consensus on the use of systemic treatments and phototherapy among adults with moderate-to-severe psoriasis. The Delphi method consists in achieving a convergence of opinions among a panel of experts using several rounds of questionnaires with controlled feedback between rounds. A two-part Delphi questionnaire was administered online to French psoriasis experts. In the first part, 180 items related to the prescription of systemic treatments and phototherapy for adult patients with moderate-to-severe psoriasis were grouped into 21 sections covering different lines of treatment and different forms of cutaneous psoriasis. The experts voted on each proposal using an ordinal 7-point Likert scale. The second part comprised 11 open-ended questions about special indications for each therapeutic class. These were converted into 101 questions for subsequent rounds. Consensus was deemed to have been reached if more than 80% of the experts agreed with a given proposal. Three rounds of questionnaires were sequentially sent to 35 participants between November 2021 and March 2022. Thirty-three (94%) completed all three rounds. For plaque psoriasis, only methotrexate was recommended by the experts as first-line systemic treatment (89% of votes). Cyclosporin was advocated in pustular and erythrodermic psoriasis, and acitretin was suggested for hyperkeratotic and palmoplantar psoriasis. In the event of failure of or intolerance to non-biological systemic treatments, guselkumab, risankizumab, ixekizumab or secukinumab were recommended by more than 80% of the experts. Tumor Necrosis Factor (TNF) inhibitors remain useful for patients with cardiovascular risk factors. Special indications were provided for each therapeutic class (methotrexate/narrowband ultraviolet B phototherapy, psoralen/ultraviolet A phototherapy, cyclosporin, acitretin, apremilast, TNF inhibitors, interleukin (IL)-12/23 inhibitors, IL-17(R)A inhibitors, and IL-23 inhibitors). This expert consensus statement indicate that newly available IL-17 and IL-23 inhibitors may be favored over TNF and IL-12/23 inhibitors as first-line biologics. The Centre of Evidence of the French Society of Dermatology has drawn up a decision-making algorithm to guide clinicians in the therapeutic management of moderate-to-severe psoriasis.

15 March 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
BHBruno Halioua
Bruno Halioua
FMF. Maccari
F. Maccari
AFAnne-Claire Fougerousse
Anne-Claire Fougerousse
JPJ. Parier
J. Parier
ZRZ. Reguiai
Z. Reguiai
EEE. Esteve
E. Esteve

1 July 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
AFAnne-Claire Fougerousse
Anne-Claire Fougerousse
ZRZiad Reguiai
Ziad Reguiai
ARAude Roussel
Aude Roussel
PBPierre-André Bécherel
Pierre-André Bécherel